Ticker LaunchSPAC · Searching for a target · FLSC
Frazier Life Sciences Acquisition Corp. II
Frazier Life Sciences Acquisition Corp. II (FLSC) is a blank-check company (SPAC) that raised $75M in its initial public offering on Oct 14, 2026, listing on Nasdaq Capital Market. It has not announced a definitive business combination agreement. Goodwin Procter advised the SPAC and White & Case advised the underwriters on the IPO.
- Status
- Searching for a target
- Ticker
- FLSC
- IPO date
- Oct 14, 2026
- IPO size
- $75M
- IPO exchange
- Nasdaq Capital Market
- SPAC counsel (IPO)
- Goodwin Procter and Appleby
- Underwriters' counsel (IPO)
- White & Case
More on this SPAC for subscribers
- Trust balance and value per share
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Oct 14, 2026
- All filings on EDGAR CIK 2153598
Other SPAC IPOs from 2026
- Pine Tree Acquisition Corp.Oct 6, 2026 · $100M
- Southport Acquisition Corp. IIOct 2, 2026 · $200M
- ASPAC I Mini Acquisition Corp.Sep 30, 2026
- Bluerock Acquisition Corp. IISep 25, 2026 · $150M
- Live Oak Acquisition Corp. VISep 23, 2026 · $200M
- Leader's Advantage Acquisition Corp.Sep 21, 2026 · $150M